Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-04 Sale | 2024-03-06 4:46 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 17,411 | $4.2145 | $73,379 | 313,569 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:24 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 16,777 | $6.2338 | $104,584 | 205,980 (Direct) | View |
| 2022-03-01 Sale | 2022-03-02 9:26 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 15,601 | $11.25 | $175,492 | 266,307 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 6:39 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 20,465 | $18.28 | $374,017 | 171,708 (Direct) | View |
| 2020-03-02 Sale | 2020-03-04 5:00 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 17,758 | $10.23 | $181,670 | 159,473 (Direct) | View |
| 2020-01-02 Sale | 2020-01-06 5:25 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 4,020 | $15.93 | $64,021 | 147,231 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-16 Option Award | 2024-02-21 4:50 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 125,000 | $0 | 330,980 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:08 pm | N/A 2033-02-15 | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 110,200 | $0 | 300,257 (Direct) | View |
| 2022-08-26 Exercise | 2022-08-29 5:02 pm | N/A 2022-12-06 | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 1,250 | $0 | 190,057 (Direct) | View |
| 2022-08-26 Exercise | 2022-08-29 5:02 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 1,250 | $3.12 | 190,057 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:26 pm | N/A 2032-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 110,200 | $0 | 266,307 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:15 pm | N/A 2031-02-23 | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 110,200 | $0 | 269,673 (Direct) | View |
| 2020-02-26 Option Award | 2020-02-28 6:01 pm | N/A 2030-02-25 | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development | 100,000 | $0 | 247,231 (Direct) | View |